Eric A. Wold

naval research laboratory

H指数:19

被引数:1,934

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phenazine-Based Synthetic Biology to Signal Between Cells and Electrodes

基于吩嗪的合成生物学在细胞和电极之间发出信号

Biotechnology and Bioengineering

IF3.6

2026-02-070

OAAI

A Staphylococcus aureus Virulence Inhibitor Identified by SaeRS Refactoring and Screening in Bacillus subtilis

ACS SYNTHETIC BIOLOGY

IF3.9

2025-04-010

PRE

Discovery of Novel Oleamide Analogues as Brain-Penetrant Positive Allosteric Serotonin 5-HT2C Receptor and Dual 5-HT2C/5-HT2A Receptor Modulators

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2023-07-184

PRE

Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2022-01-0428

Oleamide Analogues as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT2C and 5-HT2A Receptors

FASEB JOURNAL

IF4.2

2021-05-140

PRE

Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2021-04-0626

PRE

Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases

选择性靶向Sigma-1受体的小分子药物治疗神经系统疾病

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2020-10-2859

PREAI

Discovery of 4-Phenylpiperidine-2-Carboxamide Analogues as Serotonin 5-HT2C Receptor-Positive Allosteric Modulators with Enhanced Drug-like Properties

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2020-06-2215

OAAI

Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2020-04-0764

OAAI

Structure-activity relationship studies on Bax activator SMBA1 for the treatment of ER-positive and triple-negative breast cancer

Bax激活剂SMBA1治疗ER阳性和三阴性乳腺癌的构效关系研究

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-09-0115

OAAI

Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target

ACS CHEMICAL NEUROSCIENCE

IF3.9

2018-12-1229

OAAI

Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2018-08-14113

OAAI

Regio- and stereospecific synthesis of oridonin D-ring aziridinated analogues for the treatment of triple-negative breast cancer via mediated irreversible covalent warheads

冬凌草甲素D-环氮丙啶类似物的区域和立体特异性合成，用于通过介导的不可逆共价弹头治疗三阴性乳腺癌

CANCER RESEARCH

IF16.6

2018-07-010

PRE

Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT2C Receptor

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2018-04-0530

OAAI

Regio- and Stereospecific Synthesis of Oridonin D-Ring Aziridinated Analogues for the Treatment of Triple-Negative Breast Cancer via Mediated Irreversible Covalent Warheads

冬凌草甲素D-环氮杂环吡啶类似物的区域和立体特异性合成，用于通过介导的不可逆共价弹头治疗三阴性乳腺癌

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2018-03-1237

OAAI

Therapeutic Potential of Oridonin and Its Analogs: From Anticancer and Antiinflammation to Neuroprotection

冬凌草甲素及其类似物的治疗潜力: 从抗癌和抗炎到神经保护

MOLECULES

IF4.6

2018-02-2298

OAAI

Ulcerative Jejunoileitis Presenting as Protein-losing Enteropathy: A Diagnostic and Therapeutic Dilemma

AMERICAN JOURNAL OF GASTROENTEROLOGY

IF7.6

2017-10-010

PRE

Drug Discovery Targeting Bromodomain-Containing Protein 4

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2017-03-02240

OAAI

Discovery and development of natural product oridonin-inspired anticancer agents

天然产物冬凌草甲素激发的抗癌药物的发现和开发

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2016-10-01172

OAAI

Inorganic Arsenic-Related Changes in the Stromal Tumor Microenvironment in a Prostate Cancer Cell-Conditioned Media Model

ENVIRONMENTAL HEALTH PERSPECTIVES

IF9.8

2016-07-0119

OAAI

Eric A. Wold

个人简介

教育背景

工作经历

荣誉奖项

研究方向